Celldex Therapeutics, Inc. CLDX
NASDAQ · United States · Health Technology
$32.18-0.23 (-0.71%)
Market closed· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Market closed· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
| Quarter | Report date | Actual EPS | Estimated EPS | EPS surprise | Actual revenue | Revenue surprise | Price reaction |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 2026-08-06 | -0.94 | -1.06 | +11.0% | $22.00K | -97.0% | +1.6%$41.06→$41.71 |
| Q1 2026 | 2026-05-07 | -1.18 | -1.13 | -4.4% | — | — | -1.2%$34.39→$33.97 |
| Q4 2025 | 2026-02-25 | -1.22 | -1.00 | -22.0% | — | — | +23.3%$24.84→$30.64 |
| Q3 2025 | 2025-11-10 | -1.01 | -0.89 | -13.5% | — | — | +6.4%$22.90→$24.37 |
| Q2 2025 | 2025-08-07 | -0.85 | -0.84 | -1.2% | — | — | — |
| Q1 2025 | 2025-05-08 | -0.81 | -0.74 | -9.5% | — | — | — |
| Q4 2024 | 2025-02-27 | -0.71 | -0.71 | 0.0% | — | — | — |
| Q3 2024 | 2024-11-06 | -0.64 | -0.67 | +4.5% | — | — | — |
The price reaction is the change from the last close before the announcement date to the first close after it - the report may land before the open, during the session or after the close, so this window covers all three. Not investment advice.